Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia.

Patients with pneumonia treated in the internal medicine department (IMD) are often at risk of healthcare-associated pneumonia (HCAP). The importance of HCAP is controversial. We invited physicians from 72 IMDs to report on all patients with pneumonia hospitalized in their department during 2 weeks (one each in January and June 2010) to compare HCAP with community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP). We analysed 1002 episodes of pneumonia: 58.9% were CAP, 30.6% were HCAP and 10.4% were HAP. A comparison between CAP, HCAP and HAP showed that HCAP patients were older (77, 83 and 80.5 years; p < 0.001), had poorer functional status (Barthel 100, 30 and 65; p < 0.001) and had more risk factors for aspiration pneumonia (18, 50 and 34%; p < 0.001). The frequency of testing to establish an aetiological diagnosis was lower among HCAP patients (87, 72 and 79; p < 0.001), as was adherence to the therapeutic recommendations of guidelines (70, 23 and 56%; p < 0.001). In-hospital mortality increased progressively between CAP, HCAP and HAP (8, 19 and 27%; p < 0.001). Streptococcus pneumoniae was the main pathogen in CAP and HCAP. Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA) caused 17 and 12.3% of HCAP. In patients with a confirmed aetiological diagnosis, the independent risk factors for pneumonia due do difficult-to-treat microorganisms (Enterobacteriaceae, P. aeruginosa or MRSA) were HCAP, chronic obstructive pulmonary diseases and higher Port Severity Index. Our data confirm the importance of maintaining high awareness of HCAP among patients treated in IMDs, because of the different aetiologies, therapy requirements and prognosis of this population.

[1]  J. Dorca,et al.  Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  A. Akram,et al.  Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  J. Pépin,et al.  Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. , 2011, The Journal of antimicrobial chemotherapy.

[4]  M. Schlueter,et al.  Practice patterns for antibiotic de-escalation in culture-negative healthcare-associated pneumonia , 2010, Infection.

[5]  T. Welte,et al.  Rethinking the concepts of community-acquired and health-care-associated pneumonia. , 2010, The Lancet. Infectious diseases.

[6]  A. Liapikou,et al.  Validation of the American Thoracic Society-Infectious Diseases Society of America guidelines for hospital-acquired pneumonia in the intensive care unit. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  M. Niederman,et al.  Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia , 2009, Current opinion in infectious diseases.

[8]  L. Aguilar,et al.  Management in the emergency room of patients requiring hospital treatment of community-acquired pneumonia. , 2009, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[9]  Y. Hasegawa,et al.  Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. , 2009, Chest.

[10]  S. Corrao,et al.  Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. , 2009, Annals of internal medicine.

[11]  J. Fox,et al.  Viral Infection in Adults Hospitalized With Community-Acquired Pneumonia , 2008, Chest.

[12]  S. Corrao,et al.  Can CAP guideline adherence improve patient outcome in internal medicine departments? , 2008, European Respiratory Journal.

[13]  M. Kollef,et al.  Health care-associated pneumonia: identification and initial management in the ED. , 2008, The American journal of emergency medicine.

[14]  M. Niederman,et al.  Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  F. Baquero,et al.  Factors impacting on length of stay and mortality of community-acquired pneumonia. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  C. Eizaguirre,et al.  Neumonía en el anciano mayor de 80 años con ingreso hospitalario , 2008 .

[17]  M. Serra-Prat,et al.  Differences in the etiology of community-acquired pneumonia according to site of care: a population-based study. , 2007, Respiratory medicine.

[18]  M. Kollef,et al.  Health Care-Associated Pneumonia and Community-Acquired Pneumonia: a Single-Center Experience , 2007, Antimicrobial Agents and Chemotherapy.

[19]  J. Dorca,et al.  Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. , 2007, Archives of internal medicine.

[20]  V. Novack,et al.  Characteristics of low-risk patients hospitalized with community-acquired pneumonia. , 2007, European journal of internal medicine.

[21]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  R. Holman,et al.  Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. , 2005, JAMA.

[23]  Marin H Kollef,et al.  Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. , 2005, Chest.

[24]  M. Owings,et al.  Infectious disease hospitalizations among older adults in the United States from 1990 through 2002. , 2005, Archives of internal medicine.

[25]  A. Torres,et al.  Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. , 2005, American journal of respiratory and critical care medicine.

[26]  G. Giannelli,et al.  Treatment of community-acquired pneumonia: a descriptive study in an Apulian department of internal medicine. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[27]  A. Bilbao,et al.  Pacientes ingresados por neumonía adquirida en la comunidad: estudio comparativo en función de la especialidad del servicio médico responsable , 2005 .

[28]  A. Bilbao,et al.  [Patients hospitalized with community-acquired pneumonia: a comparative study of outcomes by medical specialty area]. , 2005, Archivos de bronconeumologia.

[29]  G. Lo Pinto,et al.  [MIPS: multicenter Italian pneumonia study. Results of an observational, prospective and multicenter study on the clinical approach to community-acquired pneumonia]. , 2004, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

[30]  J. Picazo,et al.  Estudio de las infecciones respiratorias en el adulto ingresado en servicios de medicina interna y neumología. Estudio DIRA , 2003 .

[31]  M. Fine,et al.  Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. , 1998, JAMA.

[32]  J. S. Santos,et al.  Neumonía adquirida en la comunidad que requiere ingreso hospitalario. Una comparación del manejo clínico, consumo de recursos y pronóstico entre diferentes especialidades médicas , 2001 .